Promis Neurosciences Inc <PMN.O>: Chardan Capital Markets raises target price to $33 from $20
PMN•Related News
Nasdaq trade halt continues <PC.O> reason not available at 10:38 AM
PC•
Trump shows irritation with Netanyahu before White House talks on Iran
SPY•
RxSight Inc <RXST.O>: UBS cuts target price to $5.5 from $9
RXST•
Amazon winds down most flagship AI models in strategy overhaul, Business Insider reports
AMZN•
BD EVP, Chief Revenue Officer Michael Feld sells 75 shares at $157.13 each, worth $11,784.75
BDX•